75.000
−0,27%
2026-10-19
Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +70.2% | +74.2% | 3 / 3 | -8.8% | -1.58 pp | +2.53 pp | +38.1% | 0.01 | 7.70 | 393 | −8,8% | 29,1 | +38,4% | 7.70 | 9.79 | −21,4% |
| Pts | 12 | 12 | 12 | 0 | 4 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 75.000 (close price on 2026-10-19)EPS (TTM): 9.745
Financial charts
1.Revenue & growth
VND bn393Q2/26
1.Revenue & growth
VND bn393Q2/26
2.Profit & growth
VND bn22,1Q2/26
3.Profit mix (Penman)
VND bn198Q2/26
4.Margins & cost structure
%25.1%Q2/26
5.Returns & cash cycle
% · days
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn2.221Q2/26
8.Funding & debt health
VND bn · times2.221Q2/26
9.Revenue backlog
VND bn972Q2/26
10.Valuation
times · %7,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.765Q2/26
Adjusted EPS growth, latest quarter
70.2%
Average adjusted EPS growth, 3 quarters
74.2%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26